Anti-Hu CD13 Purified

Anti-Hu CD13 Purified

• CAS Number: 9007-83-4
• Clone: WM15
• Format: Purified
• Buffer: Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
• References & Citations: *Favaloro EJ, Browning T, Facey D: CD13 (GP150 aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated. Exp Hematol. 1993 Dec21(13):1695-701. , URL: https://www.ncbi.nlm.nih.gov/pubmed/7902291?dopt=A,*McCormack E, Mujic M, Osdal T, Bruserud O, Gjertsen BT: Multiplexed mAbs: a new strategy in preclinical time-domain imaging of acute myeloid leukemia. Blood. 2013 Feb 14121(7):e34-42. doi: 10.1182/blood-2012-05-429555., URL: https://www.ncbi.nlm.nih.gov/pubmed/23243270,*Leukocyte Typing V., Schlossman S. et al. (Eds.), Oxford University Press (1995)., URL: ,*Leukocyte Typing IV., Knapp W. et al. (Eds.), Oxford University Press (1989)., URL: ,*Leukocyte Typing III., McMichael A.J. et al. (Eds.), Oxford University Press (1987)., URL: ,*Bradstock KF, Favaloro EJ, Kabral A, Kerr A, Hughes WG, Musgrove E: Myeloid progenitor surface antigen identified by monoclonal antibody. Br J Haematol. 1985 Sep61(1):11-20., URL: https://www.ncbi.nlm.nih.gov/pubmed/4052321?dopt=A,*Bradstock KF, Favaloro EJ, Kabral A, Kerr A, Hughes WG, Berndt MC, Musgrove E: Human myeloid differentiation antigens identified by monoclonal antibodies: expression on leukemic cells. Pathology. 1985 Jul17(3):392-9. , URL: https://www.ncbi.nlm.nih.gov/pubmed/3865147?dopt=A,
• Other References: *Tokuhara T, Hattori N, Ishida H, Hirai T, Higashiyama M, Kodama K, Miyake M. Clinical significance of aminopeptidase N in non-small cell lung cancer. Clin Cancer Res. 2006 Jul 112(13):3971-8., URL: https://pubmed.ncbi.nlm.nih.gov/16818694/,*Petrovic N, Schacke W, Gahagan JR, O'Conor CA, Winnicka B, Conway RE, Mina-Osorio P, Shapiro LH. CD13/APN regulates endothelial invasion and filopodia formation. Blood. 2007 Jul 1110(1):142-50., URL: https://pubmed.ncbi.nlm.nih.gov/17363739/,*Terauchi M, Kajiyama H, Shibata K, Ino K, Nawa A, Mizutani S, Kikkawa F. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells. BMC Cancer. 2007 Jul 277:140., URL: https://pubmed.ncbi.nlm.nih.gov/17655775/,